103 related articles for article (PubMed ID: 1915825)
1. [New drug forms of isosorbide dinitrate: the problem of an objective evaluation in patients with ischemic heart disease].
Martsevich SIu; Metelitsa VI; Kozyreva MP; Blagodatskikh SV; Simkhaev LS; Piotrovskiĭ VK
Farmakol Toksikol; 1991; 54(3):53-6. PubMed ID: 1915825
[TBL] [Abstract][Full Text] [Related]
2. [Dinitrosorbilong--a new Soviet anti-angina preparation. Its comparative pharmacodynamic, pharmacokinetic and clinical study].
Metelitsa VI; Martsevich SIu; Piotrovskiĭ VK; Blagodatskikh SV; Riabokon' OS
Biull Vsesoiuznogo Kardiol Nauchn Tsentra AMN SSSR; 1986; 9(2):20-4. PubMed ID: 3099808
[TBL] [Abstract][Full Text] [Related]
3. [Comparison of the effects of molsidomine retard and isosorbide dinitrate retard in patients with stable angina pectoris using an ergometry test].
Rotrekl P; Vlasínová J; Manousek J; Semrád B; Rysavý F; Lupínek Z; Meluzín J; Vlasicová I; Pirochtová I; Bocek O
Vnitr Lek; 1993 Sep; 39(9):856-64. PubMed ID: 8212639
[TBL] [Abstract][Full Text] [Related]
4. [Tolerance for the antianginal effect of nitrates. Approaches to its study].
Martsevich SIu; Shakarova SSh; Metelitsa VI; Strel'tsov AA; Vygodin VA
Ter Arkh; 1984; 56(9):46-50. PubMed ID: 6515547
[TBL] [Abstract][Full Text] [Related]
5. [Isosorbide dinitrate: correlations between its anti-anginal effect, dosage form and administration schedule].
Martsievich SIu; Metelitsa VI
Ter Arkh; 1988; 60(8):27-30. PubMed ID: 3067408
[TBL] [Abstract][Full Text] [Related]
6. [Extent of therapeutic effect and duration of 1 capsule of 120 mg isosorbide dinitrate in a slow release form].
Vogler AC; Silber S; Spiegelsberger F; Theisen K
Z Kardiol; 1989 Jul; 78(7):421-6. PubMed ID: 2672652
[TBL] [Abstract][Full Text] [Related]
7. [The relationship between the isosorbide-5-mononitrate concentration and its antianginal effect following the administration of regular and prolonged-action drug forms in patients with stenocardia of effort].
Blagodatskikh SV; Martsevich SIu; Metelitsa VI; Kutishenko NP; Kozyreva MP; Simkhaev LS; Slastinkova ID; Vakulovskaia MK
Eksp Klin Farmakol; 1995; 58(3):25-7. PubMed ID: 7663289
[TBL] [Abstract][Full Text] [Related]
8. [The acute and chronic effects of 50 mg of isosorbide 5-mononitrate with delayed action in patients with stable angina of effort].
San José Garagarza J; Ruano Calvo J; Vázquez de Prada JA; Colman Dejean T; López Somoza C; Pajarón López A
Rev Esp Cardiol; 1992 Feb; 45(2):103-10. PubMed ID: 1561466
[TBL] [Abstract][Full Text] [Related]
9. Assessment of antianginal efficacy of long-acting sustained release isosorbide dinitrate in comparison with short-acting isosorbide dinitrate.
Rao YV; Reddy KS; Wasir HS
Indian Heart J; 1991; 43(2):97-100. PubMed ID: 1752623
[TBL] [Abstract][Full Text] [Related]
10. [Evaluation of antianginal efficacy of long-term therapy with low dose isosorbide dinitrate in patients with stable angina pectoris].
Kośmicki M; Sadowski Z
Przegl Lek; 2000; 57(9):455-8. PubMed ID: 11199864
[TBL] [Abstract][Full Text] [Related]
11. [Evaluation of the antianginal efficacy of sustonit compared with other nitrate drug forms].
Metelitsa VI; Kokurina EV; Martsevich SIu; Urumbaev RK; Slastnikova ID
Ter Arkh; 1989; 61(8):27-30. PubMed ID: 2511641
[TBL] [Abstract][Full Text] [Related]
12. [Long-term therapy of stress angina pectoris by a single daily administration of 120 mg isosorbide dinitrate in retard form. Comparison of monotherapy and combination therapy with atenolol and nifedipine].
Blasini R; Brügmann U; Reiniger G; Rudolph W
Herz; 1985 Jun; 10(3):163-71. PubMed ID: 3926613
[TBL] [Abstract][Full Text] [Related]
13. [Orally administered nitroderivates: efficacy and duration of the effects of isosorbide dinitrate (author's transl)].
De Ponti C; Ciliberto GR
G Ital Cardiol; 1976; 6(6):1008-14. PubMed ID: 798708
[TBL] [Abstract][Full Text] [Related]
14. [Clinico-pharmacological study of a new Russian anti-angina preparation dinitrosorbilong].
Metelitsa VI; Martsevich SIu; Riabokon' OS; Strel'tsov AA
Ter Arkh; 1986; 58(3):45-9. PubMed ID: 3086997
[TBL] [Abstract][Full Text] [Related]
15. Efficacy of isosorbide dinitrate tape on exercise tolerance of patients with angina pectoris.
Saito M; Nobuyoshi M; Nakamura N; Nishiyama S; Haze K; Hiramori K; Ikeda M
Arzneimittelforschung; 1983; 33(9):1301-5. PubMed ID: 6685512
[TBL] [Abstract][Full Text] [Related]
16. [Development of nitrate tolerance in individual patients with stable angina pectoris in various phases of therapy with oral isosorbide dinitrate].
Kośmicki M; Szwed H; Kowalik I; Sadowski Z
Pol Merkur Lekarski; 2002 Jul; 13(73):52-5. PubMed ID: 12362508
[TBL] [Abstract][Full Text] [Related]
17. [Comparison of dinitrate isosorbide retard forms in ischemic heart disease patients with stable effort angina].
Lupanov VP; Alekseeva IA; Vasil'eva NN; Komar OA; Romasiuk SS; Naumov VG
Ter Arkh; 2000; 72(9):33-6. PubMed ID: 11076413
[TBL] [Abstract][Full Text] [Related]
18. Anti-anginal and anti-ischemic efficacy of conventional and slow release formulations of isosorbide-5-mononitrate in angina pectoris.
Thadani U
Z Kardiol; 1985; 74 Suppl 4():21-4. PubMed ID: 4096067
[TBL] [Abstract][Full Text] [Related]
19. Clinical effects of a sustained-release preparation of isosorbide dinitrate on angina pectoris.
Arakawa K; Fujino M
Clin Ther; 1980; 3(2):103-16. PubMed ID: 6778614
[TBL] [Abstract][Full Text] [Related]
20. Discordance of anti-ischemic and hemodynamic effects of captopril in stable coronary artery disease.
Winkelmann BR; Matheis G; Kleist P; Pötter S; Wohltmann D; Kaltenbach M
Coron Artery Dis; 1994 Oct; 5(10):829-44. PubMed ID: 7866603
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
